Overexpression of caveolin-1 in adult T-cell leukemia

Blood

Volumn 115, Issue 11, 2010, Pages 2220-2230

  Sawada, Shigeki ^a,b   Ishikawa, Chie ^a,b   Tanji, Hiroe ^a   Nakachi, Sawako ^a,b   Senba, Masachika ^c   Okudaira, Taeko ^b   Uchihara, Jun Nosuke ^d   Taira, Naoya ^e   Ohshiro, Kazuiku ^f   Yamada, Yasuaki ^g   Tanaka, Yuetsu ^b   Uezato, Hiroshi ^h   Ohshima, Koichi ⁱ   Sasai, Ken ^j   Burgering, Boudewijn M T ^k   Dodon, Madeleine Duc ^l   Fujii, Masahiro ^m   Sunakawa, Hajime ^b   Mori, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d Naha City Hospital   (Japan)

^e Heartlife Hospital   (Japan)

^f Children's Medical Center   (Japan)

^g NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^h UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

ⁱ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j Kobe MI R and D Center   (Japan)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l UNIVERSITÉ DE LYON   (France)

^m NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TAX PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEUKEMOGENESIS; LYMPH NODE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; T CELL LEUKEMIA; WESTERN BLOTTING;

EID: 77950413259     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-08-240044     Document Type: Article

References (51)

1. Burgermeister E, Liscovitch M, Röcken C, Schmid RM, Ebert MPA. Caveats of caveolin-1 in cancer progression. Cancer Lett. 2008;268(2): 187-201.
2. Goetz JG, Lajoie P, Wiseman SM. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev. 2008;27(4):715-735.
3. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005;288(3):C494-C506.
4. Scherer PE, Lewis RY, Volonte D, et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 1997;272(46):29337-29346. (Pubitemid 27498228)
5. Fra AM, Williamson E, Simons K, Parton RG. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J Biol Chem. 1994;269(49):30745-30748. (Pubitemid 24377549)
6. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982; 79(6):2031-2035.
7. Matsuoka M, Jeang K-T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270-280. (Pubitemid 46480972)
8. Massagué J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell. 1996;85(7):947-950.
9. Massagué J, Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 2000;19(8):1745-1754. (Pubitemid 30204386)
10. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17(11): 3091-3100. (Pubitemid 28254381)
11. Höllsberg P, Ausubel LJ, Hafler DA. Human T cell lymphotropic virus type I-induced T cell activation: resistance to TGF-β1-induced suppression. J Immunol. 1994;153(2):566-573. (Pubitemid 24206285)
12. Arnulf B, Villemain A, Nicot C, et al. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-β1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood. 2002;100(12):4129-4138. (Pubitemid 35396881)
13. Hidaka T, Nakahata S, Hatakeyama K, et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood. 2008;112(2):383-393.
14. Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood. 2004;103(7):2753-2760. (Pubitemid 38393034)
15. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981;294(5843): 770-771.
16. Popovic M, Sarin PS, Robert-GurroffM, et al. Isolation and transmission of human retrovirus (human T-cell leukemia virus). Science. 1983;219(4586):856- 859.
17. Koeffler HP, Chen ISY, Golde DW. Characterization of a novel HTLV-infected cell line. Blood. 1984;64(2):482-490.
18. Miyoshi I, Kubonishi I, Sumida M, et al. A novel T-cell line derived from adult T-cell leukemia. Gann. 1980;71(1):155-156.
19. Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer. 1984;34(2):221-228.
20. Maeda M, Shimizu A, Ikuta K, et al. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia: analysis of T cell receptor gene rearrangement. J Exp Med. 1985;162(6): 2169-2174.
21. Ohtani K, Nakamura M, Saito S, Nagata K, Sugamura K, Hinuma Y. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res. 1989; 17(4):1589-1604.
22. Tanaka Y, Yoshida A, Takayama Y, et al. Heterogeneity of antigen molecules recognized by antitax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses. Jpn J Cancer Res. 1990;81(3):225-231.
23. Yoshida T, Miyagawa E, Yamaguchi K, et al. IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II. Int J Cancer. 2001;91(1):99-108.
24. Teruya H, Tomita M, Senba M, et al. Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules. Retrovirology. 2008;5:86.
25. Sasai K, Ikeda Y, Ihara H, Honke K, Taniguchi N. Caveolin-1 regulates the functional localization of N-acetylglucosaminyltransferase III within the Golgi apparatus. J Biol Chem. 2003;278(28): 25295-25301. (Pubitemid 36835277)
26. Matsumoto K, Shibata H, Fujisawa JI, et al. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol. 1997;71(6):4445-4451. (Pubitemid 27204134)
27. McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard DW. Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol Cell Biol. 1996;16(5):2083-2090.
28. Geleziunas R, Ferrell S, Lin X, et al. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKα cellular kinases. Mol Cell Biol. 1998;18(9): 5157-5165.
29. Iha H, Kibler KV, Yedavalli VRK, et al. Segregation of NF-κB activation through NEMO/IKK by Tax and TNFα: implications for stimulus-specific interruption of oncogenic signaling. Oncogene. 2003;22(55):8912-8923.
30. van den Heuvel APJ, Schulze A, Burgering BM. Direct control of caveolin-1 expression by FOXO transcription factors. Biochem J. 2005;385(Pt 3): 795-802.
31. Mori N, Morishita M, Tsukazaki T, et al. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREB-binding protein/p300. Blood. 2001;97(7):2137-2144.
32. Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A. 2006;103(3):720-725.
33. Tahir SA, Ren C, Timme TL, et al. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res. 2003;9(10 Pt 1):3653-3659.
34. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986;5(11):2883-2888.
35. Goh WC, Sodroski J, Rosen C, Essex M, Haseltine WA. Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. Science. 1985; 227(4691):1227-1228.
36. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood. 1998;91(12):4624-4631.
37. Pierce JW, Schoenleber R, Jesmok G, et al. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 1997;272(34):21096-21103.
38. Gorelik L, Flavell RA. Transforming growth factor- in T-cell biology. Nat Rev Immunol. 2002; 2(1):46-53.
39. Lee DK, Kim B-C, Brady JN, Jeang K-T, Kim S-J. Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor- signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem. 2002; 277(37):33766-33775.
40. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP. Caveolin-1 regulates transforming growth factor (TGF)-/SMAD signaling through an interaction with the TGF- type I receptor. J Biol Chem. 2001;276(9):6727-6738.
41. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF- receptor. Nature. 1994;370(6488):341-347.
42. Tahir SA, Yang G, Ebara S, et al. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 2001;61(10): 3882-3885. (Pubitemid 32720945)
43. Bartz R, Zhou J, Hsieh J-T, Ying Y, Li W, Liu P. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Int J Cancer. 2008;122(3):520-525. (Pubitemid 350308942)
44. Hatanaka M, Maeda T, Ikemoto T, Mori H, Seya T, Shimizu A. Expression of caveolin-1 in human T cell leukemia cell lines. Biochem Biophys Res Commun. 1998;253(2):382-387. (Pubitemid 29026712)
45. Sasaki H, Nishikata I, Shiraga T, et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood. 2005;105(3):1204-1213. (Pubitemid 40170895)
46. Mori N, Fujii M, Ikeda S, et al. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood. 1999;93(7):2360-2368. (Pubitemid 29153640)
47. Suzuoki M, Miyamoto M, Kato K, et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer. 2002; 87(10):1140-1144. (Pubitemid 35418110)
48. Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation: protein sorting at the level of the endoplasmic reticulum. J Biol Chem. 2001;276(6):4398-4408. (Pubitemid 37371532)
49. Ayala GE, Dai H, Tahir SA, et al. Stromal anti-apoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res. 2006;66(10): 5159-5164. (Pubitemid 43844938)
50. Yang G, Addai J, Wheeler TM, et al. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol. 2007; 38(11):1688-1695. (Pubitemid 47589092)
51. Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer. 1994;73(11):2753-2758. (Pubitemid 24166262)